This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n15http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/chemspider/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/chebi/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/wikipedia/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/kegg-compound/
n11http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n17http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/pubchem-substance/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB02134/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02134
rdf:type
n5:Drug
n5:description
A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed)
n5:group
experimental
owl:sameAs
n11:DB02134 n12:DB02134
dcterms:title
Xanthine
adms:identifier
n4:XAN n7:1188 n8:DB02134 n9:C00385 n14:17712 n15:1151 n16:Xanthine n17:46507575
n5:synthesisReference
John P. Zikakis, "Preparation of high purity xanthine oxidase from bovine milk." U.S. Patent US4172763, issued October 30, 1979.
n5:IUPAC-Name
n6:271B40FC-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4102-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4101-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B40FE-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B40FF-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4100-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B40FA-363D-11E5-9242-09173F13E4C5 n6:271B4112-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B40F8-363D-11E5-9242-09173F13E4C5 n6:271B40FB-363D-11E5-9242-09173F13E4C5 n6:271B4113-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B40F9-363D-11E5-9242-09173F13E4C5
n5:pKa
n6:271B4114-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4108-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4109-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4103-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4104-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4106-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4105-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4107-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
69-89-6
n5:Bioavailability
n6:271B410E-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4110-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4111-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B410D-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B410C-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B410F-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B40FD-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B410A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B410B-363D-11E5-9242-09173F13E4C5